欢迎访问《中国实验方剂学杂志》编辑部网站!
射干麻黄汤治疗小儿咳嗽变异性哮喘的系统评价及Meta分析
DOI:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

基金项目:


Systematic Reviews and Meta Analysis of Cough Variant Asthma in Children with Shegan Mahuang Tang
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:运用循征医学方法对射干麻黄汤治疗小儿咳嗽变异性哮喘进行系统评价。方法:计算机检索中国知网,维普数据库,万方数据库,同时手检相关杂志专业资料。结果:共查及文献94篇,7篇符合纳入标准,采用Jadad评分标准对每篇文章的方法学质量进行评价,属低质量文献,共收入病人470例,总优势比(OR)=2.99,95%置信区间(CI)为(1.90~4.71),合并效应检验Z=4.71(P<0.00001),差异有统计学意义。结论:现有临床证据表明,射干麻黄汤治疗小儿咳嗽变异性哮喘有效。但系统评价纳入的随机对照临床试验均属低质量文献,其疗效须进一步开展大规模的高质量临床试验研究来验证。

    Abstract:

    Objective:Evidence Based Medicine (EBM) is used to do systematic reviews on Shegan Mahuang tang (Ephedra decoction) controlling cough variant asthma (CVA) in children. Method:Data retrieval is done on the websites such as cnki, cqvip, wanfangdata and offline professional magazines. Result:Ninty-four pieces of literatures are attained and 7 pieces accord with the inclusive criteria. Jadad Criteria is adopted to assess every literature's Methodological quality, all of which are low quality ones. 470 cases are obtained. OR=2.99, 95% CI of 1.90 to 4.71, test for overall effect:Z=4.71(P<0.000 01). Therefore, the difference is statistically significant. Conclusion:The existed clinical evidences shows, Shegan Mahuang tang is effecitve to control cough variant asthma (CVA) in children. However, randonmized control clinical trials are subsumed by systematic reviews belong to low quality ones, so Shegan Mahuang tang's therapeutic effect need to be further examined by a large scale of high quality of clinical trials.

    参考文献
    相似文献
    引证文献
引用本文

陈照南,惠萍,宋天云,黄崇政.射干麻黄汤治疗小儿咳嗽变异性哮喘的系统评价及Meta分析[J].中国实验方剂学杂志,2012,18(19):1~4

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:2012-04-08
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期:
  • 出版日期:

地址:北京东直门内南小街16号

邮编:100700

电话:010-84076882

E-mail:syfjx_2010@188.com

中国实验方剂学杂志 ® 2024 版权所有

技术支持:北京勤云科技发展有限公司